Variability in Practices of Compounding Budesonide for Eosinophilic Esophagitis.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 33538420.
- Also identified by DOI 10.14309/ajg.0000000000001170 and PMC identifier 9161310.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Little is known about the use of compounded steroids for eosinophilic esophagitis (EoE). We conducted a telephone survey of all compounding pharmacies in Michigan and queried about practices and costs of compounded budesonide for EoE. Of 68 Michigan pharmacies, 93% responded, and 20 (29%) offer compounded budesonide suspension for EoE. Formulations, dose, and instructions for use varied across pharmacies. The mean cost for a 30-day supply was $74.50. Although few compounding pharmacies offer budesonide suspension and there are substantial variations in formulations, this may be a significantly more affordable treatment option for many.
Medical subject headings
- Budesonide
- Drug Compounding
- Eosinophilic Esophagitis
- Glucocorticoids